Strategies for reopening in the forthcoming COVID-19 era in China.
作者信息
Guan Wei-Jie, Zhong Nan-Shan
机构信息
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, China.
出版信息
Natl Sci Rev. 2022 Apr 6;9(3):nwac054. doi: 10.1093/nsr/nwac054. eCollection 2022 Mar.
Abstract
摘要
相似文献
1
Strategies for reopening in the forthcoming COVID-19 era in China.
Natl Sci Rev. 2022 Apr 6;9(3):nwac054. doi: 10.1093/nsr/nwac054. eCollection 2022 Mar.
2
Reopening strategies, mobility and COVID-19 infections in Europe: panel data analysis.
BMJ Open. 2022 Feb 9;12(2):e055938. doi: 10.1136/bmjopen-2021-055938.
3
Reopening International Borders without Quarantine: Contact Tracing Integrated Policy against COVID-19.
Int J Environ Res Public Health. 2021 Jul 14;18(14):7494. doi: 10.3390/ijerph18147494.
4
Evaluation of reopening strategies for educational institutions during COVID-19 through agent based simulation.
Sci Rep. 2021 Mar 17;11(1):6264. doi: 10.1038/s41598-021-84192-y.
5
The paradox of re-opening schools in Zimbabwe in the COVID-19 era.
Public Health Pract (Oxf). 2021 Nov;2:100070. doi: 10.1016/j.puhip.2020.100070. Epub 2020 Dec 24.
6
Reopening Schools and the Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections in Israel: A Nationwide Study.
Clin Infect Dis. 2021 Dec 16;73(12):2265-2275. doi: 10.1093/cid/ciab035.
7
Recommendations for Dermatology Office Reopening in the Era of COVID-19.
J Drugs Dermatol. 2020 Jul 1;19(7):e1-e9. doi: 10.36849/JDD.2020.5293.
8
Reopening after lockdown: the influence of working-from-home and digital device use on sleep, physical activity, and wellbeing following COVID-19 lockdown and reopening.
Sleep. 2022 Jan 11;45(1). doi: 10.1093/sleep/zsab250.
9
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases.
Intern Emerg Med. 2020 Aug;15(5):783-786. doi: 10.1007/s11739-020-02391-3. Epub 2020 Jun 8.
10
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases: Comment.
Intern Emerg Med. 2021 Oct;16(7):2017-2018. doi: 10.1007/s11739-021-02647-6. Epub 2021 Feb 10.
引用本文的文献
1
Healthcare-Seeking behavior for acute respiratory infections in a community population in Southwest China during the 2021-2023 influenza seasons.
BMC Infect Dis. 2025 Jul 29;25(1):957. doi: 10.1186/s12879-025-11301-x.
2
Clinical characteristics and prediction model of re-positive nucleic acid tests among Omicron infections by machine learning: a real-world study of 35,488 cases.
BMC Infect Dis. 2024 Dec 18;24(1):1406. doi: 10.1186/s12879-024-10297-0.
3
Clinical characteristics and prognostic factors of COVID-19 infection among cancer patients during the December 2022 - February 2023 Omicron variant outbreak.
Front Med (Lausanne). 2024 May 30;11:1401439. doi: 10.3389/fmed.2024.1401439. eCollection 2024.
4
Neoadjuvant Chemotherapy Is Effective in Those Infected With SARS-CoV-2: The Real-World Experience of a Large Chinese Breast Cancer Center.
J Breast Cancer. 2024 Jun;27(3):176-186. doi: 10.4048/jbc.2023.0299. Epub 2024 May 2.
5
Enhanced immunity against SARS-CoV-2 in returning Chinese individuals.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2300208. doi: 10.1080/21645515.2023.2300208. Epub 2024 Jan 8.
6
Factors Influencing the Behavioral Intentions and Use Behaviors of Telemedicine in Patients With Diabetes: Web-Based Survey Study.
JMIR Hum Factors. 2023 Dec 28;10:e46624. doi: 10.2196/46624.
7
Temporary impact on medical system and effectiveness of mitigation strategies after COVID-19 policy adjustment in China: a modeling study.
Front Public Health. 2023 Dec 1;11:1259084. doi: 10.3389/fpubh.2023.1259084. eCollection 2023.
8
Clinical characteristics and prognostic nomograms of 12555 non-severe COVID-19 cases with Omicron infection in Shanghai.
BMC Infect Dis. 2023 Sep 16;23(1):606. doi: 10.1186/s12879-023-08582-5.
9
Impact of the COVID-19 pandemic on cancer healthcare utilization in southwestern China on March 2021.
Cancer Med. 2023 Jun;12(12):13821-13833. doi: 10.1002/cam4.6028. Epub 2023 May 11.
10
China ends its zero-COVID-19 policy: New challenges facing mental health services.
Asian J Psychiatr. 2023 Apr;82:103485. doi: 10.1016/j.ajp.2023.103485. Epub 2023 Jan 26.
本文引用的文献
1
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination.
Nat Med. 2022 Mar;28(3):481-485. doi: 10.1038/s41591-022-01705-6. Epub 2022 Jan 20.
2
Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern.
Cell Res. 2022 Jan;32(1):103-106. doi: 10.1038/s41422-021-00590-x. Epub 2021 Nov 23.
3
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
Emerg Microbes Infect. 2021 Dec;10(1):1751-1759. doi: 10.1080/22221751.2021.1969291.
Zotero 插件